U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07580092) titled 'Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease' on April 21.
Brief Summary: The aim of this study is to compare the construct validity (convergent validity and known-groups validity) and responsiveness of EQ-5D-3L and EQ-5D-5L in patients with inflammatory joint disease. The study is based on prospectively collected data through the Swedish Rheumatology Quality Register (SRQ).
Study Start Date: Nov. 30, 2023
Study Type: OBSERVATIONAL
Condition:
Ankylosing Spondylitis
Rheumatoid Arthritis (RA)
Psoriatic Arthritis
Polyarthritis
Inflammatory Joint Disease (IJD)
Interventio...